Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan A Fallowfield

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
Alimentary Pharmacology & Therapeutics|March 26, 2026
Systematic Review: Imaging-Based Morphological Criteria for Liver Cirrhosis-A Call to StandardiseMei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan, et al.
Cell Genomics|May 25, 2023
Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potentialRodrigo Carlessi, Elena Denisenko, Ebru Boslem, et al.
Med (New York, N.Y.)|April 7, 2026
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysisTsubasa Tsutsumi, Nicole Shu Ying Tang, Cheng Han Ng, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverAndrew S Perry, Niran Hadad, Emeli Chatterjee, et al.
Journal of Hepatology|April 27, 2021
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter studyJitao Wang, Zhiyun Hou, Jianxin Liu, et al.
Cell Reports. Medicine|December 10, 2024
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverAndrew S Perry, Niran Hadad, Emeli Chatterjee, et al.
Nature|March 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Plos Medicine|March 1, 2017
Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trialVictoria K Snowdon, Neil J Lachlan, Anna M Hoy, et al.
Alimentary Pharmacology & Therapeutics|March 26, 2026
Systematic Review: Imaging-Based Morphological Criteria for Liver Cirrhosis-A Call to StandardiseMei Chin Lim, Ethan Joo Wei Quek, Talia Yi Hui Chan, et al.
Cell Genomics|May 25, 2023
Single-nucleus RNA sequencing of pre-malignant liver reveals disease-associated hepatocyte state with HCC prognostic potentialRodrigo Carlessi, Elena Denisenko, Ebru Boslem, et al.
Med (New York, N.Y.)|April 7, 2026
Comparative efficacy of phase 2-3 therapies for non-cirrhotic metabolic dysfunction-associated steatohepatitis: An updated network meta-analysisTsubasa Tsutsumi, Nicole Shu Ying Tang, Cheng Han Ng, et al.
Medrxiv : the Preprint Server for Health Sciences|February 14, 2024
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverAndrew S Perry, Niran Hadad, Emeli Chatterjee, et al.
Journal of Hepatology|April 27, 2021
Safety and immunogenicity of COVID-19 vaccination in patients with non-alcoholic fatty liver disease (CHESS2101): A multicenter studyJitao Wang, Zhiyun Hou, Jianxin Liu, et al.
Cell Reports. Medicine|December 10, 2024
A prognostic molecular signature of hepatic steatosis is spatially heterogeneous and dynamic in human liverAndrew S Perry, Niran Hadad, Emeli Chatterjee, et al.
Nature|March 13, 2025
Hepatic stellate cells control liver zonation, size and functions via R-spondin 3Atsushi Sugimoto, Yoshinobu Saito, Guanxiong Wang, et al.
Pageof 7